KRISTIN YAMAMOTO: Open Payments
NPI 1093142770 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $673
Food & beverage: $558Education: $115
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $291 |
| Janssen Biotech, Inc. | 3 | $140 |
| Amgen Inc. | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| ABBVIE INC. | 1 | $30 |
| PFIZER INC. | 1 | $24 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: TEZSPIRE, FASENRA, TREMFYA, TAVNEOS, RINVOQ, OCTAGAM IMMUNE GLOBULIN (HUMAN), DAWNZERA, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
